8039 — TAIFLEX Scientific Co Income Statement

0.000.00%

Last trade - 00:00

TechnologyBalancedSmall CapContrarian

Annual income statement for TAIFLEX Scientific Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,766	9,405	8,722	8,151	9,938
Cost of Revenue
Gross Profit	2,079	2,199	2,079	1,792	2,138
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	7,747	8,453	8,074	7,663	9,302
Operating Profit	1,019	952	648	488	636
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	966	941	877	482	701
Provision for Income Taxes
Net Income After Taxes	784	745	692	361	532
Minority Interest
Net Income Before Extraordinary Items
Net Income	773	735	700	423	593
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	773	736	715	437	601
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	3.48	2.86	2.74	1.65	2.5
Dividends per Share